The roles of different porcine cytochrome P450 enzymes and cytochrome b5A in skatole metabolism

Agergaard, 1992, Absorption from the gastrointestinal tract and liver turnover of skatole, 15 Anzenbacherová, 2005, Model systems based on experimental animals for studies on drug metabolism in man: (mini)pig cytochromes P450 3A9 and 2E1, Basic and Clinical Pharmacology and Toxicology, 96, 244, 10.1111/j.1742-7843.2005.pto960316.x Babol, 1998, Relationship between oxidation and conjugation metabolism of skatole in pig liver and concentrations of skatole in fat, Journal of Animal Science, 76, 829, 10.2527/1998.763829x Bæk, 1997, Identification of selected metabolites of skatole in plasma and urine from pigs, Journal of Agricultural Food and Chemistry, 45, 2332, 10.1021/jf9605862 Balk, 1987, Emerging models in the USA: swine, woodchucks and the hairless guinea pig, 311 Bertz, 1997, Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions, Clinical Pharmacokinetics, 32, 210, 10.2165/00003088-199732030-00004 Billen, 2009, The role of porcine cytochrome b5A and cytochrome b5B in the regulation of cytochrome P45017A1 activities, Journal of Steroid Biochemistry and Molecular Biology, 113, 98, 10.1016/j.jsbmb.2008.11.012 Bonneau, 1982, Compounds responsible for boar taint, with special emphasis on androstenone: a review, Livestock Production Science, 9, 687, 10.1016/0301-6226(82)90017-3 de Lange, 1995, Entire males vs castrates for pork production - financial benefits to the producer, Ontario Swine Research Review, 41 Diaz, 2000, Metabolism of 3-methylindole by porcine liver microsomes: responsible cytochrome P450 enzymes, Toxicological Sciences, 55, 284, 10.1093/toxsci/55.2.284 Diaz, 2000, Role of aldehyde oxidase in the hepatic in vitro metabolism of 3-methylindole in pigs, Journal of Agricultural Food and Chemistry, 48, 833, 10.1021/jf990805u Diaz, 1999, Identification of phase I metabolites of 3-methylindole produced by pig liver microsomes, Drug Metabolism and Disposition, 27, 1150 Friis C 1993. Disposition of skatole in male and female pigs. Proceedings of the 5th European ISSX Meeting, Tours, France, 26–29 September, 133p. C Friis 1995. Is boar taint related to sex differences or polymorphism of skatole metabolism?. In Proceedings of the EAAP Working Group on Production and Utilization of Meat from Entire Male Pigs. Milton Keynes, UK, September 1995. Jensen, 1998, Microbial production of skatole in the digestive tract of entire male pigs, 41 Juskevich, 1987, Comparative metabolism in food-producing animals: programs sponsored by the center for veterinary medicine, Drug Metabolism Reviews, 18, 345, 10.3109/03602538708998312 Kojima, 2004, Cloning of six full-length cDNAs encoding pig cytochrome p450 enzymes and gene expression of these enzymes in the liver and kidney, Journal of Health Science, 50, 518, 10.1248/jhs.50.518 Madan, 2002, vitro approaches for studying the inhibition of drug-metabolizing enzymes identifying the drug-metabolizing enzymes responsible for the metabolism of drugs, 217 Matal, 2009, Porcine CYP2A19, CYP2E1 and CYP1A2 forms are responsible for skatole biotransformation in the reconstituted system, Neuroendocrinology Letters, 30, 36 McLaughlin, 2010, Deletion of microsomal cytochrome b5 profoundly affects hepatic and extrahepatic drug metabolism, Molecular Pharmacology, 78, 269, 10.1124/mol.110.064246 Moe, 2008, Gene expression profiles in liver of pigs with extreme high and low levels of androstenone, BMC Veterinary Research, 4, 29, 10.1186/1746-6148-4-29 Monshouwer, 1998, Characterization of cytochrome P450 isoenzymes in primary cultures of pig hepatocytes, Toxicology In Vitro, 12, 715, 10.1016/S0887-2333(98)00053-8 Peacock, 2008, The effect of a c.-8G>T polymorphism on the expression of cytochrome b5A and boar taint in pigs, Animal Genetics, 39, 15, 10.1111/j.1365-2052.2007.01674.x Prunier, 2006, A review of the welfare consequences of surgical castration in piglets and the evaluation of non-surgical methods, Animal Welfare, 15, 277, 10.1017/S0962728600030487 Rendic, 1997, Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers and inhibitors, Drug Metabolism Reviews, 29, 413, 10.3109/03602539709037591 Schenkman, 2003, The many roles of cytochrome b5, Pharmacology and Therapeutics, 97, 139, 10.1016/S0163-7258(02)00327-3 Skaanlid, 2007, Is bupropion a more specific substrate for porcine CYP2E than chlorzoxazone and p-nitrophenol?, Basic and Clinical Pharmacology and Toxicology, 101, 159, 10.1111/j.1742-7843.2007.00083.x Squires, 1997, Relationship between cytochrome P450IIEI in liver and levels of skatole and its metabolites in intact male pigs, Journal of Animal Science, 75, 2506, 10.2527/1997.7592506x Terner, 2006, The role of CYP2A and CYP2E1 in the metabolism of 3-methylindole in primary cultured porcine hepatocytes, Drug Metabolism and Disposition, 34, 848, 10.1124/dmd.105.008128 Thornton-Manning, 1991, Metabolic activation of the pneumotoxin, 3-methylindole, by vaccinia-expressed cytochrome P450s, Biochemical and Biophysical Research Communications, 181, 100, 10.1016/S0006-291X(05)81387-7 Thornton-Manning, 1996, Metabolism of 3-methylindole by vaccinia-expressed P450 enzymes: correlation of 3-methyleneindolenine formation and protein-binding, Pharmacology and Experimental Therapeutics, 276, 21 Tsiaoussis, 2001, Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems, Liver Transplantation, 7, 2, 10.1053/jlts.2001.20845 Wiercinska, 2010, Chlorzoxazone metabolism by porcine cytochrome P450 enzymes and the effect of cytochrome b5, Drug Metabolism and Disposition, 38, 857, 10.1124/dmd.109.030528 Yamazaki, 1996, Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, CLZ, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes, Biochemical Pharmacology, 52, 301, 10.1016/0006-2952(96)00208-0 Yamazaki, 2002, Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli, Protein Expression and Purification, 24, 329, 10.1006/prep.2001.1578